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Abstract
Purpose: The optimal duration of targeted systemic antibiotic therapy after lavage for native septic 
hand arthritis is unknown. Significant variation in daily clinical practice has been described across 
different centers.
Methods: We assessed variables associated with remission in septic hand and wrist arthritis by 
means of a retrospective cohort study of adult patients hospitalized for septic native joint arthritis 
of the hand and wrist between March 2007 and March 2013 at 2 university hospitals in Switzerland. 
The data review was principally focused on antibiotic regimens and surgical procedures.
Results: We included 80 consecutive cases of hand arthritis (median age, 56 years; 26 women and 
54 men; 16 immunocompromised individuals). All patients underwent median of a 1 surgical 
irrigation and received concomitant systemic antibiotic therapy for a median duration of 28 days 
including 5 days of intravenous therapy. Remission was achieved in 74 cases (93%); however, there 
were 26 episodes (33%) of non-infectious sequelae such as osteoarthritis or persistent pain. No 
variables were associated with remission or sequelae in the multivariate logistic regression analysis. 
Moreover, outcomes were identical for <5 days versus ≥ 5 days of intravenous therapy and for <2 
weeks versus >4 weeks of total antibiotic treatment.
Conclusions: The rate of post-surgical remission for adult native joint hand septic arthritis is 
high and independent of immune suppression, number of surgical debridement procedures, and 
modality/duration of antibiotic therapy.
Type of study/Level of evidence: III, retrospective study.
Keywords: Antibiotic; Hand arthritis; Septic joint arthritis; Joint infection; Joint irrigation
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Introduction
Few studies have evaluated the infectious recurrence of native joint hand and wrist septic 
arthritis in adults. Accordingly, the optimal or minimal concomitant antibiotic treatment regimen 
remains controversial [1]. For this reason, surgeons and physicians often treat hand arthritis in 
analogy to hip and knee joint infection. Several different regimens have been recommended such 
as 2 weeks of intravenous therapy for streptococci, 3 to 4 weeks of intravenous for staphylococci 
and Gram-negative bacteria and 4 weeks of therapy for immunosuppressed patients or those with 
joint pathology such as severe osteoarthritis [2,3]. Other physicians only prescribe intravenous 
and subsequently oral antibiotics for a total of 2 weeks after surgical debridement and drainage 
or for longer periods of time without additional justification [1,4,5]. Assuming adequate surgical 
drainage, septic arthritis of the hand and wrist is theoretically treatable with a short course of oral 
antibiotics that have good oral bioavailability and synovial penetration [1]. The aim of this study was 
to compare clinical parameters associated with remission in native joint hand and wrist arthritis, 
placing an emphasis on surgical and antibiotic-related treatment modalities in order to inform the 
optimal treatment approach.
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Methods
Setting: The Geneva and Vaud University Hospitals are 2 tertiary 
centers in Western Switzerland (Hôpitaux Universitaires Genève 
[HUG] and Centre Hospitalier Universitaire Vaudois [CHUV]). 
Each center is equipped with a Hand Surgery Unit and 2 teams of 
surgeons and infectiologists. Open debridement, drainage, and 
irrigation for arthritis were usually performed as an emergency. 
During the first 2 days after surgery, the joint was immobilized with a 
cast. Associated pain was managed with the maximum recommended 
doses of paracetamol and ibuprofen and the addition of morphine 
as necessary. Steroid use is generally avoided for adult septic hand 
arthritis [6]. Revision surgery was performed at the discretion of the 
attending surgeon. Selection of the antibiotic regimen was performed 
by infectiologists. Surgeons (C. T. M., T. R., N. L., M. G., and E. G.) 
and an infectious diseases expert (I. U.) retrospectively recorded 
demographic, therapy, and outcome variables in an Excel® spreadsheet 
in 2 independent groups. Any disagreements between the groups 
were resolved by consensus. Database assembly was concluded on 
June 30, 2016.
Study design, definitions and criteria: We performed 
a retrospective dual-center cohort study of all adult patients 
hospitalized for acute native joint infectious arthritis of hand and 
wrist between March 2007 and March 2013. Eligible cases had a 
minimum follow-up period of 2 months at the same Hand Surgical 
Unit. We applied several exclusion criteria. Since arthritis can be 
caused by various bacterial and viral pathogens, we only included 
infections with purulent synovial fluid and confirmed bacterial 
growth on intraoperative specimens. To enhance specificity, we 
only considered samples with positive cultures on agar plates and 
significant growth. Cases with growth in liquid enrichment culture 
only were excluded. Other exclusion criteria included episodes of 
recurrent arthritis; patients who did not undergo surgical drainage; 
rheumatoid polyarthritis; the presence of an implant; adjacent 
osteomyelitis; neoplasms; adjacent bone trauma; amputation as 
the primary therapeutic approach; viral, fungal, mycobacterial, 
mycoplasmal, gonococcal, brucellar, parasitic, and nocardial arthritis; 
and pediatric cases [7-9]. We defined remission as complete clinical 
and laboratory resolution of the infection for a minimal active follow-
up period of 2 months after the completion of antibiotic treatment. 
Recurrence was evidenced by new signs of infection with the same 
microorganism at least 2 weeks after the completion of treatment for 
the initial episode. Sequelae were non-infections handicaps persisting 
at 2 months follow-up. The study protocol was approved by the ethics 
committees of both participating hospitals (No. 08-017R, No. 15-014, 
and Protocol 258/15). 
Statistical analyses: We compared patient groups using Pearson 
χ2 or Wilcoxon rank-sum tests. Separate unmatched logistic regression 
analyses were used to determine associations with the outcomes 
“remission” and “sequelae.” Independent variables with p ≤ 0.2 in 
the univariate analysis were introduced stepwise into a multivariate 
analysis unless variables were related to surgical interventions, 
antibiotic treatment, or the care facility, in which case they were 
automatically included in the final model [10]. Using these criteria, the 
final variables were age, number of surgical interventions, duration 
of intravenous antibiotic treatment, duration of total antibiotic 
treatment, immune suppression, and the tertiary center. Incubation 
times and antibiotic durations were assessed as both categorical and 
continuous variables. For analysis as a categorical variable, the total 
duration of antibiotic therapy was divided into 0 to 14 days, 15 to 
n=80 Center 1  n=39 p-value* Center 2   n=41
Female/male 10 (26%)/29 (74%) 0.201 16 (39%)/25 (61%)
Median age 59 years 0.227 53 years
Wrist arthritis 18 (46%) 0.001 2 (5%)
Immune suppression+ 11 (28%) 0.074 5 (12%)
Intravenous drug abuse 4 (10%) 0.642 3 (7%)
Median serum C-reactive protein level 83 mg /L 0.035 39 mg/L
Bacteremia 4 (10%) 0.149 1 (2%)
Median no. of surgical interventions 1 0.105 1
Second look 11 (28%) 0.074 5 (12%)
Median duration of antibiotic treatment 28 days 0.847 25 days
≤ 14 days 10 (26%) 0.114 5 (12%)
>14 to 28 days 11 (28%) 0.114 20 (49%)
>28 days 18 (46%) 0.114 16 (39%)
Median duration of intravenous treatment 8 days 0.001 2 days
≤ 5 days 11 (28%) 0.001 36 (88%)
>5 days 28 (72%) 0.001 5 (12%)
Median delay from onset to surgery 2 days 0.028 3 days
Duration of delay >7 days 16 (41%) 0.066 9 (22%)
Remission 35 (90%) 0.361 39 (95%)
Median length of hospital stay 8 days 0.002 4 days
Table 1: Comparison of adult patients with hand and wrist native joint septic arthritis from 2 university hospitals in Switzerland.
*Statistically significant results are italicized and bolded.
+Immunosuppression was defined as diabetes mellitus, steroids, HIV disease, pregnancy, or active cancer.
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28 days, and >28 days, corresponding to local prescription practices. 
Intravenous antibiotic therapy was similarly stratified as 0 to 5 days 
and >5 days. Incubation time prior to surgical drainage was arbitrarily 
stratified at ≤ 7 days and >7 days. Furthermore, we graphically plotted 
remission rate against the duration of antibiotic administration to 
detect potential thresholds of minimal antibiotic duration. A p-value 
≤ 0.05 (2-tailed) was statistically significant.
Results
Patients: We screened 90 consecutive cases of native septic hand 
and wrist arthritis; of these, 3 patients met multiple exclusion criteria 
and 7 were addicted to intravenous drugs and thereby excluded from 
the study. Thus, 80 cases (26 women and 54 men) with a median 
age of 56 years (range, 18 to 94 years) were included in the analysis. 
Twenty patients (25%) were immunocompromised as a result of 
diabetes mellitus (9 patients), chronic steroid medication (3 patients), 
untreated human immunodeficiency virus (2 patients), severe 
alcoholism (3 patients), or oncological treatment for an active cancer 
(3 patients). Detailed patient data stratified by center are summarized 
in Table 1. CHUV had significantly more cases of wrist arthritis, 
longer durations of intravenous antibiotic use, and longer hospital 
stays than HUG (p<0.05).
Origin of infection and pathogens: The origin of infection 
was not reported in 20 cases (25%). The remaining 60 causes were 
domestic animal bites and other trauma (n=38), surgical site 
infections (n=6), intravenous drug abuse (n=6), and locoregional 
arthritis following an adjacent soft tissue infection (n=10). The 
median serum level of C-reactive protein at admission was 53 mg/L 
(range, 2mg/L to 410 mg/L) and 5 patients had bacteremia. Among 
28 different microbiologic combinations, the predominant pathogen 
was Staphylococcus aureus in 26 cases (33%), of which 2 were 
methicillin-resistant. Twenty episodes (25%) were due to streptococci 
S. pyogenes (n=7) and S. dysgalactiae (n=4). The most frequent Gram-
negative bacteria were Pasteurella multocida (n=4) and Pseudomonas 
aeruginosa (n=4).
Treatment: Patients underwent surgical treatment with a median 
delay of 2 days after infection onset (range, 0 to 48 days). Surgical re-
intervention was performed a median of 3 days after the first operation. 
All patients received systemic antibiotic therapy. Irrigation was 
performed with 0.9% saline without local antibiotics or antiseptics.
Wound dressings were changed once per day during the first 2 post-
operative days. We identified 24 different intravenous antibiotic 
regimens and 18 different oral antibiotic regimens. Amoxicillin/
clavulanate was the most frequently prescribed drug (65 episodes; 
81%). Quinolones were used in 18 cases (23%), clindamycin in 19 
cases (24%), and co-trimoxazole in 4 cases (5%). There was no specific 
reason for choosing non-beta-lactam treatment, but this selection 
was often related to an anamnestic penicillin allergy. In 5 cases of 
staphylococcal infection (6%), rifampicin was used in combination 
therapy despite the absence of foreign material. The median duration 
of total antibiotic therapy was 28 days (range, 1 to 132 days): therapy 
was ≤ 14 days in 15 cases (19%), 15 to 28 days in 31 cases (39%), 
and >28 days in 34 cases (43%). The median duration of intravenous 
therapy was 5 days (range, 0 to 47 days): the duration was <5 days in 
47 cases (59%) and >5 days in 33 cases (41%). Immunocompromised 
patients tended to have longer treatment durations (median values, 
32 days vs. 24 days in immunocompetent patients), but this difference 
was not statistically significant (p =0.12).
Outcomes: Seventy-four patients (93%) were still in remission 
after a median active follow-up period of 6.5 months (range, 3 to 
63 months). In the crude comparison, there were no significant 
associations between any variables and remission (Table 2). Twenty-
seven patients (33%) experienced sequelae including osteoarthritis 
(15 patients), deformation (2 patients), digital flexion deformity (2 
patients), hypoesthesia (3 patients), and persistent pain (5 patients).
We performed unmatched logistic regression analyses with the 
outcomes “remission” (Table 3) and “sequelae” (Table 4). There 
were no significant associations between any variables and remission 
(Table 3). Intravenous therapy <5 days had the same outcome of 
>5 days (Odds Ratio [OR]: 0.2; 95% Confidence Interval [CI]: 0.1-
3.9) and <2 weeks of total antibiotic treatment yielded the same 
outcome as >4 weeks (OR: 1.0; 95% CI: 0.1-20). Female sex was the 
only variable associated with sequelae (OR: 4.0; 95% CI: 1.1-15.2; 
Table 4). We were unable to detect a threshold antibiotic duration 
for recurrence or sequelae (data not shown). All final models were 
statistically adequate in terms of goodness-of-fit, with area under the 
n=80 Recurrence n=6 p-value* Remission  n=74
Female/male 1 (17%)/5 (83%) 0.389 25 (34%)/49 (66%)
Median age 58 years 0.277 55 years
Immune suppression+ 3 (50%) 0.056 13 (18%)
Intravenous drug abuse 0 (0%) 0.43 7 (9%)
Median serum leukocyte count 8.4 g/L 0.058 10.6 G/L
Bacteremia 0 (0%) 0.511 5 (7%)
Second surgical look 3 (50%) 0.056 13 (18%)
Antibiotic treatment ≤ 14 days 1 (17%) 0.423 14 (19%)
Antibiotic treatment 14 to 28 days 1 (17%) 0.423 30 (41%)
Antibiotic treatment >28 days 4 (67%) 0.423 30 (41%)
Median delay from onset to surgery 0 day 0.476 2 days
Duration of delay >7 days 4 (67%) 0.052 21 (28%)
Non-infectious sequelae 4 (67%) 0.063 22 (30%)
Table 2: Comparison of adult patients with recurrent hand and wrist native joint septic arthritis and remission.
*Statistically significant results are italicized and bolded.
+Immunosuppression was defined as diabetes mellitus, steroids, HIV disease, pregnancy, or active cancer.
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curve values of 0.86 (95% CI: 0.62-1.00) and 0.81 (95% CI: 0.70-0.92), 
respectively.
Discussion
We report our experience treating 80 patients with septic native 
joint hand and wrist arthritis hospitalized in 2 different university 
hospitals in Western Switzerland. There were no significant 
associations between surgical parameters and remission. Likewise, 
we were unable to determine a threshold antibiotic duration 
for recurrence or sequelae. The odds ratios of antibiotic-related 
parameters and associated variability were often close to a value of 
1, indicating equality. Specifically, outcomes did not vary when the 
duration of intravenous therapy was less than or greater than 5 days 
or when the total antibiotic duration was less than 2 weeks or more 
than 4 weeks. These observations were also valid for a subgroup of 
Univariate analysis Multivariate analysis
 n = 80 Odds ratio (95% confidence interval) Odds ratio (95% confidence interval)
Age (continuous variable) 1.0 (0.9-1.0) 1.0 (0.9-1.1)
Hospitalization at Center 1 vs. Center 2 0.8 (0.2-9.8) 0.6 (0.1-9.0)
Immune suppression+ 0.2 (0.1-1.2) 0.3 (0.1-1.6)
Serum C-reactive protein level at admission 1.0 (1.0-1.1) -
Serum leukocyte count at admission 1.4 (0.9-2.1) -
Delay from onset to surgery 0.9 (0.9-1.0) -
Duration of delay >7 days 0.2 (0.1-1.2) 0.2 (0.1-1.4)
Number of surgical interventions 0.4 (0.2-0.9) 0.6 (0.3-1.4)
Second look 0.2 (0.4-1.2) 0.2 (0.1-2.0)
Duration of antibiotic treatment 0.9 (0.9-1.0) 0.9 (0.9-1.1)
>28 days vs. ≤ 14 days 0.7 (0.3-1.4) 1.0 (0.1-20.0)
Duration of intravenous treatment 1.0 (0.9-1.0) 1.0 (0.9-1.1)
>5 days vs. ≤ 5 days 0.1 (0.1-1.1) 0.2 (0.1-3.9)
Table 3: Variables associated with remission after native joint septic hand and wrist arthritis (logistic regression).
*Statistically significant results are italicized and bolded.
+ Immunosuppression was defined as diabetes mellitus, steroids, HIV disease, pregnancy, or active cancer.
 Univariate analysis Multivariate analysis
n = 80 Odds ratio (95% confidence interval) Odds ratio (95% confidence interval)
Female 4.1 (1.5-11.1) 4.0 (1.1-15.2)
Age (continuous variable) 1.0 (1.0-1.0) 1.0 (0.9-1.1)
Immunosuppression+ 1.3 (0.4-4.1) -
Serum C-reactive protein level at admission 1.0 (1.0-1.0) -
Serum leukocyte count at admission 1.4 (0.9-1.1) -
Delay from onset to surgery 1.1 (0.9-1.1) 1.0 (0.9-1.1)
Duration of delay >7 days 0.7 (0.3-2.1) -
Number of surgical interventions 1.4 (0.8-2.4) 2.9 (0.9-1.1)
Second look 1.8 (0.6-5.7) 0.2 (0.1-2.0)
Duration of antibiotic treatment 1.0 (0.9-1.1) 0.9 (0.9-1.1)
>28 days vs. ≤ 14 days 1.0 (0.3-3.5) 1.3 (0.3-7.2)
Duration of intravenous treatment 0.9 (0.8-1.0) 0.8 (0.6-1.0)
>5 days vs. ≤ 5 days 0.3 (0.1-0.9) -
Table 4: Variables associated with non-infectious sequelae after native joint septic hand and wrist arthritis (logistic regression).
*Statistically significant results are italicized and bolded.
+Immunosuppression was defined as diabetes mellitus, steroids, HIV disease, pregnancy, or active cancer.
immunocompromised patients.
Few reports have addressed the appropriate or optimal antibiotic 
regimen for hand septic arthritis [1,4,11]. Angly et al. [11] investigated 
31 adult patients who were operated for digital arthritis and reported 
zero recurrence of infection after surgery with an antibiotic regimen 
comprised of a median of 2 days intravenous therapy and 17 days oral 
therapy. Sendi et al. [4] retrospectively analyzed 101 cases of surgery 
for hand and wrist arthritis in adults and described a median of 2 days 
intravenous antibiotic therapy and 14 days of oral antibiotic therapy 
for acute cases. In this study, the corresponding duration for chronic 
infections was 28 days and cure of infection was noted in all episodes, 
with a good functional outcome in 79% of patients. To date, several 
studies have acknowledged the utility of short antibiotic durations for 
infectious arthritis, especially in children. Kim et al. [12] compared 
short and long durations of antibiotic treatment among 20 children 
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and found that intravenous therapy <10 days was sufficient after 
surgical drainage for hip arthritis. The results of a randomized clinical 
trial conducted by Peltola et al. [13] favored a 10-day rather than 30-
day course of antimicrobial treatment for childhood septic arthritis. 
Jagodzinki et al. [14] prospectively demonstrated the efficacy of 3 
days of intravenous therapy followed by 3 weeks of oral antibiotic 
therapy in a cohort of 70 children with septic arthritis in joints of 
the upper extremities. Consistent with our findings, another report 
indicated that early conversion from parenteral to oral antibiotics 
after a median of 7 days was equally effective to later conversion for 
the treatment of pediatric arthritis in a cohort of 186 children [15]. A 
cut-off of 7 days for conversion from intravenous to oral antibiotic 
therapy was similarly confirmed in a trial comparing 7 and 14 
days of parenteral antibiotic therapy in 130 pediatric cases of acute 
hematogenous bone and joint infection [16].
In the present study, we observed sequelae in 33% of cases, 
consistent with the findings of Ross et al. [17] (sequelae in 26% of 
cases) and Vispo-Seara et al. [5] (sequelae in 20% of cases) in various 
contexts of septic arthritis. Our regression analysis did not reveal 
significant associations between any variables and sequelae except for 
female sex, suggesting that treatment modality is secondary to patient 
baseline characteristics when predicting the likelihood of recurrence 
and sequelae.
Our study had some limitations. First, the generalizability of our 
findings is limited given the nature of the study as a retrospective, 
dual-center investigation in a resource-rich setting. Second, we were 
unable to control for some important variables such as intraoperative 
severity scores, suction drain duration, or radiologic scores. Third, 
our analysis may have overlooked long-term sequelae in patients who 
underwent treatment elsewhere after the initial surgery; however, 
we believe that this scenario is unlikely as our facilities are the only 
tertiary centers for infections of the hand and wrist in the geographic 
area. Fourth, we did not investigate alternative treatments such as 
repetitive arthrocentesis or continuous irrigation [1,9]. Additionally, 
we cannot exclude bias in terms of confounding by indication; e.g., 
patients who were assumed to have a favorable outcome may have been 
preferentially prescribed short antibiotic courses. Finally, the current 
sample size was too small to allow for stratification by pathogen 
and antibiotic resistance pattern. S. aureus was the predominant 
pathogen in less than a third of patients and resistant pathogens 
were encountered in less than 10% of all episodes. As a general rule, 
therapeutic recommendations do not take into account the pathogen 
itself and rely on clinical presentation. Moreover, we demonstrated 
similar outcomes in previous studies comparing S. aureus and S. 
pyogenes in hand arthritis and flexor tenosynovitis [18,19]. For these 
reasons, we did not incorporate additional pathogen-related variables 
into our final models.
Conclusion
The results of the present retrospective dual-center study suggest 
that a total of 2 weeks of post-surgical antibiotic administration (5 days 
intravenous therapy followed by 10 day of oral therapy) is sufficient 
for septic joint arthritis of the hand and produces similar outcomes 
to 4-week antibiotic therapy. A future randomized controlled trial is 
necessary to confirm these findings for clinical application.
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